Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

medipha sante sn - meropenem trihydrate, meropenem - pdr for soln inj/inf - 500 milligram - carbapenems

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

medipha sante sn - meropenem trihydrate, meropenem - pdr for soln inj/inf - 1 grams - carbapenems

Καναδάς - Αγγλικά - Health Canada

sun pharma canada inc - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems

Καναδάς - Αγγλικά - Health Canada

sun pharma canada inc - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Καναδάς - Αγγλικά - Health Canada

eugia pharma inc. - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg

Καναδάς - Αγγλικά - Health Canada

eugia pharma inc. - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g

Καναδάς - Αγγλικά - Health Canada

pfizer canada ulc - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems

Καναδάς - Αγγλικά - Health Canada

pfizer canada ulc - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Ισραήλ - Αγγλικά - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - meropenem as trihydrate - powder for solution for injection - meropenem as trihydrate 500 mg/vial - meropenem - meropenem - meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Ισραήλ - Αγγλικά - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - meropenem as trihydrate - powder for solution for injection - meropenem as trihydrate 500 mg/vial - meropenem - meropenem - meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.